Contamination Control in Nursing with Filtration: Part 1: Filters Applied to Intravenous Fluids and Point-of-use Hospital Water

Journal of Infusion Nursing

Volumn 27, Issue 2, 2004, Pages 89-103

  Ortolano, Girolamo A ^a   Russell, Rosalind L ^a   Angelbeck, Judy A ^a   Schaffer, Jeffrey ^a   Wenz, Barry ^a  

^a PALL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DOPAMINE; FENTANYL; GENTAMICIN; HEPARIN; HYDROCORTISONE; INFUSION FLUID; MACROLIDE; MENATETRENONE; PROPOFOL; WATER;

CONTAMINATION; FILTER; FILTRATION; HOSPITAL; NURSING; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL AVAILABILITY; DRUG CONTAMINATION; EQUIPMENT CONTAMINATION; FILTRATION; GUIDELINES; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; PARTICLE SIZE; PHLEBITIS; POINT-OF-CARE SYSTEMS; SEPSIS; SOLUBILITY; WATER PURIFICATION;

EID: 1642285885     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200403000-00005     Document Type: Review

References (132)

1. Warring RH. Filters and Filtration. Morden, Surray, England: Trade and Technical Press; 1969:228.
2. Gutman RG. Membrane Filtration The Technology of Pressure-Drive Crossflow Processes. Bristol, UK: Adam Hilger; 1987:210.
3. Purchas DB, Sutherland K. Handbook of Filter Media. Oxford, UK: Elsevier Science; 2002: 549.
4. Lawson DH, Henry DA. Drug therapy reviews: intravenous fluid therapy. Am J Hosp Pharm. 1977;34:1332-1338.
5. Morrison DC. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis. Prog Clin Biol Res. 1998;397:199-207.
6. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med. 1999;27:1608-1616.
7. Horn DL, Morrison DC, Opal SM, Silverstein R, Visvanathan K, Zabriskie JB. What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin Infect Dis. 2000;31:851-858.
8. Opal SM, Gluck T. Endotoxin as a drug target. Crit Care Med. 2003;31:S57-S64.
9. Tetta C, Bellomo R, Inguaggiato P, Wratten ML, Ronco C. Endotoxin and cytokine removal in sepsis. Therapeutic Apheresis. 2002;6:109-115.
10. Rothenberg F, Schumacher JR, Rosenthal RL. Near-fatal pulmonary air embolus from presumed inadvertent pressure placed on a partially empty plastic intravenous infusion bag. Am J Cardiol. 1994;73:1035-1036.
11. Levy I, Mosseri R, Garty B. Peripheral intravenous infusion: another cause of air embolism. Acta Paediatr. 1996;85:385-386.
12. Heckmann JG, Lang CJ, Kindler K, Huk W, Erbguth FJ, Neundorfer B. Neurologic manifestations of cerebral air embolism as a complication of central venous catheterization. Crit Care Med. 2000;28:1621-1625.
13. Porea TJ, Margolin JF, Chintagumpala MM. Radiological case of the month: pulmonary air embolus with home antibiotic infusion. Arch Pediatr Adolesc Med. 2001;155:963-964.
14. Wald M, Kirchner L, Lawrenz K, Amann G. Fatal air embolism in an extremely low birth weight infant: can it be caused by intravenous injections during resuscitation? Intensive Care Med. 2003;29:630-633.
15. Laskey AL, Dyer C, Tobias JD. Venous air embolism during home infusion therapy. Pediatrics. 2002;109:E15.
16. Neff TA, Fischer JE, Schulz G, Baenziger O, Weiss M. Infusion pump performance with vertical displacement: effect of syringe pump and assembly type. Intensive Care Med. 2001;27:287-291.
17. Schulz G, Fischer J, Neff T, Banziger O, Weiss M. The effect of air within the infusion syringe on drug delivery of syringe pump infusion systems. Anaesthesist. 2000;49:1018-1023.
18. Feng ZY. Study on the particles in infusion solutions and the means to control it. Zhonghua Hu Li Za Zhi. 1994;29:519-522.
19. Backhouse CM, Ball PR, Booth S, Kelshaw MA, Potter SR, McCollum CN. Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol. 1987;39:241-245.
20. Akers MJ, Schrank GD, Russell S. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy. Am J Hosp Pharm. 1981;38:1304-1307.
21. Briceno JC, Runge TM. Tubing spallation in extracorporeal circuits: an in vitro study using an electronic particle counter. Int J Artif Organs. 1992;15:222-228.
22. Morley AR, Barron D, Thompson P, Hoenich NA, Harbottle S, Kerr DN. Surface alterations in dialysis roller pump inserts: a scanning electron microscopy study. J Biomed Eng. 1986;8:255-261.
23. Barron D, Harbottle S, Hoenich NA, Morley AR, Appleton D, McCabe JF. Particle spallation induced by blood pumps in hemodialysis tubing sets. Artif Organs. 1986;10:226-235.
24. Bahal SM, Romansky JM. Spalling and sorption of tubing for peristaltic pumps. Pharm Dev Technol. 2002;7:317-323.
25. Dewan PA, Ehall H, Edwards GA, Middleton DJ, Terlet J. Plastic particle migration during intravenous infusion assisted by a peristaltic finger pump in an animal model. Pediatr Surg Int. 2002;18:310-314.
26. Madsen H, Winding O. Release of foreign bodies (particles) by clinical use of intravenous infusion sets. Biomaterials. 1996;17:663-666.
27. Walpot H, Franke RP, Burchard WG, et al. Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy: 1. Energy dispersion electron images in the scanning electron microscope-REM/EDX. Anaesthesist. 1989;38:544-548.
28. Walpot H, Franke RP, Burchard WG, et al. The filter effectiveness of common 15-micron filters (DIN 58362): II. Scanning electron microscopy and roentgen analysis. Infusionstherapie. 1989;16:133-139.
29. Walpot H, Franke RP, Burchard WG, et al. Particulate contamination of infusion solutions and drug additives in the framework of long-term intensive therapy: 2. An animal model. Anaesthesist. 1989;38:617-621.
30. Thompson WL, Feer TD. Incomplete mixing of drugs in intravenous infusions. Crit Care Med. 1980;8:603-607.
31. Sendo T, Hirakawa M, Makino K, Nakashima K, Kataoka Y, Oishi R. Particulate contamination of lyophilized amphotericin B preparation during reconstitution process. J Clin Pharm Ther. 2001;26:87-91.
32. Jamerson BD, Dukes GE, Brouwer KL, Donn KH, Messenheimer JA, Powell JR. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy. 1994;14:47-52.
33. Hirakawa M, Makino K, Nakashima K, Kataoka Y, Oishi RJ. Evaluation of the in-line filters for the intravenous infusion of amphotericin B fluid. J Clin Pharm Ther. 1999;24:387-392.
34. Sendo T, Adachi K, Otsubo K, Aoyama T, Oishi R. In-line filter occlusion during intravenous delivery of injectable menatetrenone (vitamin K2). J Clin Pharm Ther. 1996;21:9-13.
35. Johnson CE, Roesner MP, Berman JR, Burch KJ. Administrating incompatible drugs by a retrograde intravenous infusion system. Am J Hosp Pharm. 1985;42:109-111.
36. Niemiec PW Jr, Vanderveen TW. Compatibility considerations in parenteral nutrient solutions. Am J Hosp Pharm. 1984;41:893-911.
37. Stevens RF, Wilkins KM. Use of cytotoxic drugs with an end-line filter: a study of four drugs commonly administered to paediatric patients. J Clin Pharm Ther. 1989;14:475-479.
38. Rapp RP, Bivins BA. Final in-line filtration: removal of contaminants from IV fluids and drugs. Hosp Formul. 1983 Dec;18(12):1124-1128.
39. Butler DL, Munson JM, DeLuca PP. Effect of in-line filtration on the potency of low-dose drugs. Am J Hosp Pharm. 1980;37:935-941.
40. De Muynck C, De Vroe C, Remon JP, Colardyn F. Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units. J Clin Pharm Ther. 1988;13:335-340.
41. Nazeravich DR, Otten NH. Effect of in-line filtration on delivery of gentamicin at a slow infusion rate. Am J Hosp Pharm. 1983;40:1961-1964.
42. Panadero A, Iohom G, Taj J, Mackay N, Shorten G. A dedicated intravenous cannula for postoperative use effect on incidence and severity of phlebitis. Anaesthesia. 2002;57:921-925.
43. de Dios Garcia-Diaz J, Santolaya Perrin R, Paz Martinez Ortega M, Moreno-Vazquez M. Phlebitis due to intravenous administration of macrolide antibiotics: a comparative study of erythromycin versus clarithromycin. Med Clin (Barc). 2001;116:133-135.
44. Monreal M, Oller B, Rodriguez N, et al. Infusion phlebitis in postoperative patients: when and why. Haemostasis. 1999;29:247-254.
45. Foster L, Wallis M, Paterson B, James H. A descriptive study of peripheral intravenous catheters in patients admitted to a pediatric unit in one Australian hospital. J Infus Nurs. 2002;25:159-167.
46. Danchaivijitr S, Srihapol N, Pakaworawuth S, et al. Infusion-related phlebitis. J Med Assoc Thai. 1995;78:S85-S90.
47. Catney MR, Hillis S, Wakefield B, et al. Relationship between peripheral intravenous catheter dwell time and the development of phlebitis and infiltration. J Infus Nurs. 2001;24:332-341.
48. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. J Intraven Nurs. 2001;24:19-24.
49. Kuwahara T, Asanami S, Kawauchi Y, Kubo S. Experimental infusion phlebitis: tolerance pH of peripheral vein. J Toxicol Sci. 1999;24:113-121.
50. Kuwahara T, Asanami S, Tamura T, Kubo S. Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition. 1998;14:186-190.
51. Rypins EB, Johnson BH, Reder B, Sarfeh IJ, Shimoda K. Three-phase study of phlebitis in patients receiving peripheral intravenous hyperalimentation. Am J Surg. 1990;159:222-225.
52. May J, Murchan P, MacFie J, et al. Prospective study of the aetiology of infusion phlebitis and line failure during peripheral parenteral nutrition. Br J Surg. 1996;83:1091-1094.
53. Monreal M, Quilez F, Rey-Joly C, et al. Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999;115:1576-1580.
54. Perucca R, Micek J. Treatment of infusion-related phlebitis: review and nursing protocol. J Intraven Nurs. 1993;16:282-286.
55. Scalley RD, Van CS, Cochran RS. The impact of an IV team on the occurrence of intravenous-related phlebitis: a 30-month study. J Intraven Nurs. 1992;15:100-109.
56. DeLuca PP, Rapp RP, Bivins B, McKean HE, Griffen WO. Filtration and infusion phlebitis: a double-blind prospective clinical study. Am J Hosp Pharm. 1975;32:1001-1007.
57. Evans WE, Barker LF, Simone JV. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis. Am J Hosp Pharm. 1976;33:1160-1163.
58. Bivins BA, Rapp RP, DeLuca PP, McKean H, Griffen WO Jr. Final in-line filtration: a means of decreasing the incidence of infusion phlebitis. Surgery. 1979;85:388-394.
59. Allcutt DA, Lort D, McCollum CN. Final in-line filtration for intravenous infusions: a prospective hospital study. Br J Surg. 1983;70:111-113.
60. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis: its prevention by in-line filtration. N Engl J Med. 1985;312:78-82.
61. Chamberland ME, Lyons RW, Brock SM. Effect of in-line filtration of intravenous infusions on the incidence of thrombophlebitis. Am J Hosp Pharm. 1977;34:1068-1070.
62. Rusho WJ, Bair JN. Effect of filtration on complications of postoperative intravenous therapy. Am J Hosp Pharm. 1979;36:1355-1356.
63. Johnson S. A time and money saver? Cost comparison of IV therapy with and without Pall 96 filters. Prof Nurse. 1994;10:94-96.
64. Richards C, Millar-Jones L, Alfaham M. Assessment of in-line filters to prolong the life of intravenous cannulae in cystic fibrosis patients. J Clin Pharmacol Ther. 1995;20:165-166.
65. Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann Pharmacother. 1994;28:11-16.
66. Chee S, Tan W. Reducing infusion phlebitis in Singapore hospitals using extended-life end-line filters. J Infus Nurs. 2002;25:95-104.
67. Davies AF, Vadodaria B, Hopwood B, Dexter T, Conn D. Efficacy of microfiltration in decreasing propofol-induced pain. Anaesthesia. 2002;57:557-561.
68. Leong AS. Pathologic findings in silicone spallation: autopsy and biopsy studies. Ann Acad Med Singapore. 1983;12:304-310.
69. Leong AS, Gove DW. Pathological findings in silicone spallation in vitro studies. Pathology. 1983;15:189-192.
70. Gedikoglu Y, Colak A, Benli K, Erbengi T. Reaction of rabbit lateral periventricular tissue to noninfected and infected (Staphylococcus epidermidis) shunt tubing implants: a light and transmission electron microscope study. Acta Neurochir (Wien). 1993;122(3-4):266-270.
71. Lehr HA, Brunner J, Rangoonwala R, Kirkpatrick CJ. Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle. Am J Respir Crit Care Med. 2002;165:514-520.
72. Ortolano GA, Aldea GS, Lilly K, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of antiinflammatory effects. Perfusion. 2002;17(3 Suppl):53-62.
73. Rickard CM, Wallis SC, Courtney M, Lipman J, Daley PJ. Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use: an in vitro study. J Adv Nurs. 2002;37:330-337.
74. Stratton CW. Infection related to intravenous infusions. Heart Lung. 1982;11:123-137.
75. Lieblich SE, Forman D, Berger J, Gold BD. Septicemia secondary to administration of a contaminated intravenous fluid. J Oral Maxillofac Surg. 1984;42:680-682.
76. Raad I, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: Is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol. 2001;22:136-139.
77. Driscoll DF, Bacon MN, Bistrian BR. Effects of in-line filtration on lipid particle size distribution in total nutrient admixtures. J Parenter Enteral Nutr. 1996;20:296-301.
78. Matlow AG, Kitai I, Kirpalani H, et al. A randomized trial of 72-versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol. 1999;20:487-493.
79. McLaws ML, Taylor PC. The Hospital Infection Standardised Surveillance (HISS) programme: analysis of a two-year pilot. J Hosp Infect. 2003;53:259-267.
80. Webster CS, Merry AF, Emmens DJ, Van Cotthem IC, Holland RL. A prospective clinical audit of central venous catheter use and complications in 1,000 consecutive patients. Anaesth Intensive Care. 2003;31:80-86.
81. Viale PH. Complications associated with implantable vascular access devices in the patient with cancer. J Infus Nurs. 2003;26:97-102.
82. Solomon S, Horan T, Andrus M, et al. National nosocomial infection surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control. 2002;30:458-475.
83. Lewis WJ, Sherertz RJ. Microbial interactions with catheter material. Nutrition. 1997;13:5S-9S.
84. Salzman MB, Rubin LG. Relevance of the catheter hub as a portal for microorganisms causing catheter-related infections. Nutrition. 1997;13:15S-17S.
85. Sitges-Serra A, Hernandes R, Maestro S, Pi-Suner T, Garces JM, Segura M. Prevention of catheter-related infection: the hub. Nutrition. 1997;13:30S-35S.
86. Darouiche R, Raad I. Prevention of catheter-related infections: the skin. Nutrition. 1997;13:26S-29S.
87. Raad I. Intravascular-catheter-related infections. Lancet. 1998;351:893-898.
88. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725-730.
89. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976-981.
90. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
91. Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol. 2003;24:251-256.
92. Tumbarello M, Tacconelli E, Donati KG, et al. Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:490-497.
93. Pessoa-Silva CL, Miyasaki CH, de Almeida MF, Kopelman BI, Raggio RL, Wey SB. Neonatal late-onset bloodstream infection: attributable mortality, excess of length of stay and risk factors. Eur J Epidemiol. 2001;17:715-720.
94. Liu JW, Su YK, Liu CF, Chen JB. Nosocomial bloodstream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect. 2002;50:224-227.
95. Rapoport J, Teres D, Zhao Y, Lemeshow S. Length of stay data as a guide to hospital economic performance for ICU patients. Med Care. 2003;41:386-397.
96. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore). 2002;81:466-479.
97. Hadaway LC. Skin flora and infection. J Infusion Nurs. 2003;26:44-48.
98. Ryder M. The role of biofilm in vascular catheter-related infections. New Develop Vasc Dis. 2001;2(2):15-25.
99. John T, Kopstein AB, John OC, Lai CI, Carey RB. In vitro adherence of Staphylococcus epidermidis to silicone punctual plugs and collagen implants. J Cataract Refract Surg. 2001;27:1298-1302.
100. Murga R, Miller JM, Donlan RM. Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol. 2001;39:2294-2297.
101. Dobbins BM, Kite P, Wilcox MH. Diagnosis of central venous catheter related sepsis: a critical look inside. J Clin Pathol. 1999;52:165-172.
102. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J Clin Pathol. 2002;55:824-828.
103. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-1222.
104. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567-1572.
105. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387-1392,
106. Richards C, Grassby PF. A comparison of the endotoxin-retentive abilities of two "96-h" in-line intravenous filters. J Clin Pharmacol Ther. 1994;19:199-202.
107. Vanhaecke E, De Muynck C, Remon JP, Colardyn F. Endotoxin removal by end-line filters. J Clin Microbiol. 1989;27:2710-2712.
108. Stout JE, Yu VL. Legionella in the hospital water supply: a plea for decision making based on evidence-based medicine. Infect Control Hosp Epidemiol. 2001;22:670-672.
109. Anaissie EJ, Penzak SR, Dignani MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med. 2002;162:1483-1492.
110. Squier C, Yu VL, Stout JE. Waterborne nosocomial infections. Curr Infect Dis Rep. 2000;2:490-496.
111. Ta AC, Stout JE, Yu VL, Wagener MM. Comparison of culture methods for monitoring Legionella species in hospital potable water systems and recommendations for standardization of such methods. J Clin Microbiol. 1995;33:2118-2123.
112. Arvanitidou M, Kanellou K, Constantinides TC, Katsouyannopoulos V. The occurrence of fungi in hospital and community potable waters. Lett Appl Microbiol. 1999;29:81-84.
113. Rudnick J, Beck-Sague CM, Anderson RL, Schable B, Miller JM, Jarvis WR. Gram-negative bacteremia in open-heart surgery patients traced to potable tap water contamination of pressure-monitoring equipment. Infect Control Hosp Epidemiol. 1996;17:281-285.
114. Trautmann M, Michalsky T, Heidemaire W, Radosavljevic V, Ruhnke M. Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients. Infect Control Hosp Epidemiol. 2001;22:49-52.
115. Kolmos HJ, Thuesen B, Nielsen SV, Lohmann M, Kristoffersen K, Rosdahl VT. Outbreak of infection in a burn unit due to Pseudomonas aeruginosa originating from contaminated tubing used for irrigation of patients. J Hosp Infect. 1993;4:11-21.
116. Grundmann H, Kropec A, Hartung D, Berner R, Daschner F. Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen. J Infect Dis. 1993;168:943-947.
117. Ferroni A, Nguyen B, Pron B, Quesne G, Brusset MC, Berche P. Outbreak of nosocomial urinary tract infections due to Pseudomonas aeruginosa in a pediatric surgical unit associated with tap water contamination. J Hosp Infect. 1998;39:301-307.
118. Buttery JP, Alabaster SJ, Heine RG, Scott SM, Crutchfield RA, Garland SM. Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J. 1998;17:509-513.
119. Bert F, Maubec E, Bruneau B, Berry P, Lambert-Zechovsky N. Multiresistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect. 1998;39:53-62.
120. Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis. 1989;159:708-716.
121. Burns DN, Wallace RJ Jr, Schultz ME, et al. Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis. 1991;144:1153-1159.
122. Soto LE, Bobadilla M, Villalobos Y, et al. Postsurgical nasal cellulitis outbreak due to Mycobacterium chelonae. J Hosp Infect. 1991;19:99-106.
123. Hector JS, Pang Y, Mazurek GH, Zhang Y, Brown BA, Wallace RJ Jr. Large restriction fragment patterns of genomic Myeobacterium fortuitum DNA as strain-specific markers and their use in epidemiological investigation of four nosocomial outbreaks. J Clin Microbiol. 1992;30:1250-1255.
124. Von Reyn C, Maslow JN, Barber TW, Falkinham JO III, Arbeit RD. Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS. Lancet. 1994;343:1137-1141.
125. Picardeau M, Prod'Hom G, Raskine L, Le Pennec MP, Vincent V. Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol. 1997;35:25-32.
126. Kauppinen J, Nousiainen T, Jantunen E, Mattila R, Katila ML. Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patient. Infect Control Hosp Epidemiol. 1999;20:343-345.
127. Benitez MA, Alcaide F, Rufi G, Sanuy B, Gudiol F, Martin R. Investigation of a nosocomial outbreak of Mycobacterium xenopi associated with a hospital water supply. In: Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Diego, Calif. Abstract 753.
128. Sabria M, Garcia-Nunez M, Pedro-Botet ML, et al. Presence and chromosomal subtyping of Legionella species in potable water systems in 20 hospitals of Catalonia, Spain. Infect Control Hosp Epidemiol. 2001;22:673-676.
129. Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis. 2002;2:368-373.
130. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319-325.
131. Bottiger BW, Bach A. Use of microfilters within the scope of infusion therapy. Infusionsther Transfusionsmed. 1994;21:42-51.
132. Johns T. Intravenous filters: panacea or placebo? J Clin Nurs. 1996;5:3-6.